What are the major opportunities in the Visceral Leishmaniasis market? What are the strategies for the Visceral Leishmaniasis market?

For detailed insights on the major opportunities and strategies in the Visceral Leishmaniasis market, Read More

How does the Visceral Leishmaniasis market relate to the overall economy and other similar markets?

For detailed insights on Visceral Leishmaniasis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Visceral Leishmaniasis market growth? SWOT analysis of the Visceral Leishmaniasis market.

For detailed insights on the key dynamics influencing the Visceral Leishmaniasis market growth and SWOT analysis of the Visceral Leishmaniasis industry, Read More

Global Visceral Leishmaniasis Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Visceral Leishmaniasis Global Market Report 2025

Name: Visceral Leishmaniasis Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment (Antiparasitic, Antifungal, Other Treatments), By Diagnosis Method (Serological Tests, Molecular Tests, Microscopy, Culture Methods), By Route Of Administration (Oral, Injectable, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Visceral Leishmaniasis Market Overview

• Visceral Leishmaniasis market size has reached to $1 billion in 2024

• Expected to grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Rise In Malnutrition Fueling The Growth Of The Market Due To Weakened Immunity And Increasing Susceptibility

• Market Trend: Advancements In Oral Antiparasitic Therapies For Visceral Leishmaniasis

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Visceral Leishmaniasis Market?

Visceral leishmaniasis, also known as kala-azar, is a severe parasitic disease caused by Leishmania species, transmitted through infected sandfly bites. It affects internal organs such as the spleen, liver and bone marrow, causing prolonged fever, weight loss, anemia and organ enlargement. If untreated, it can be fatal, making early diagnosis and treatment crucial.

The main treatment types of visceral leishmaniasis are antiparasitic, antifungal, and others. Antiparasitic refers to medications or treatments that specifically target and eliminate parasites from the body by disrupting their biological processes, preventing their growth, reproduction, or survival. It is diagnosed with various diagnostic methods such as serological tests, molecular tests, microscopy, and culture methods, and administered through several routes of administration consisting of oral, injectable, and other alternative methods. The distribution channels encompass hospital pharmacies, online pharmacies, and retail pharmacies and are used by various end users, including hospitals, home care, specialty clinics, and others.

Visceral Leishmaniasis Market Size and growth rate 2025 to 2029: Graph

What Is The Visceral Leishmaniasis Market Size 2025 And Growth Rate?

The visceral leishmaniasis market size has grown strongly in recent years. It will grow from $1.0 billion in 2024 to $1.06 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing disease burden, rising government funding, the introduction of amphotericin B, development of miltefosine, growing awareness campaigns, improved healthcare access in endemic regions, and establishment of public-private partnerships.

What Is The Visceral Leishmaniasis Market Growth Forecast?

The visceral leishmaniasis market size is expected to see strong growth in the next few years. It will grow to $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing investment in vaccine development, enhanced global disease surveillance programs, increasing public-private collaborations, improved funding for neglected tropical diseases and development of gene-based therapies. Major trends in the forecast period include clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing, artificial intelligence (AI)-driven drug discovery, nanotechnology-enhanced drug delivery, next-generation sequencing for parasite analysis, wearable biosensors for early detection, blockchain for medical supply chain management, smartphone-based diagnostic tools and three-dimensional (3D) bioprinting for personalized treatment research.

The forecast of 5.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of liposomal amphotericin B and rapid diagnostic tests sourced from India and Brazil, thereby delaying life-saving treatments and elevating tropical disease program expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Visceral Leishmaniasis Market Segmented?

1) By Treatment: Antiparasitic, Antifungal, Other Treatments

2) By Diagnosis Method: Serological Tests, Molecular Tests, Microscopy, Culture Methods

3) By Route Of Administration: Oral, Injectable, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Antiparasitic: Pentavalent Antimonials, Miltefosine, Paromomycin, Sitamaquine, Combination Therapy

2) By Antifungal: Amphotericin B, Liposomal Amphotericin B (AmBisome), Azoles, Echinocandins, Polyenes

3) By Other Treatments: Immunotherapy, Monoclonal Antibodies, Vaccine-Based Approaches, photodynamic therapy, Gene Therapy

What Is Driving The Visceral Leishmaniasis Market? Rise In Malnutrition Fueling The Growth Of The Market Due To Weakened Immunity And Increasing Susceptibility

The rise in malnutrition is expected to propel the growth of the visceral leishmaniasis market going forward. Malnutrition is a health condition caused by inadequate or unbalanced nutrient intake essential for proper body functioning. The rise in malnutrition is due to food insecurity, as it limits access to nutritious food, leading to undernourishment and micronutrient deficiencies, which weaken the immune system. Malnutrition impairs immune function, making the body more vulnerable to infections such as visceral leishmaniasis. Nutrient deficiencies weaken defense mechanisms, increasing the risk of severe disease and complications. For instance, in July 2024, according to the Food and Agriculture Organization, an Italy-based specialized agency of the United Nations, the number of undernourished people rose to 723.8 million in 2022, up from 708.7 million in 2021. Therefore, the rise in malnutrition is driving the growth of the visceral leishmaniasis industry.

Who Are The Major Players In The Global Visceral Leishmaniasis Market?

Major companies operating in the visceral leishmaniasis market are Pfizer Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Aurobindo Pharma Limited, Cipla Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd, Xellia Pharmaceuticals, Knight Therapeutics Inc, Gufic Biosciences Ltd., United Biotech Private Limited, DNDi, TLC.

What Are The Key Trends Of The Global Visceral Leishmaniasis Market? Advancements In Oral Antiparasitic Therapies For Visceral Leishmaniasis

Major companies operating in the visceral leishmaniasis market are focusing on developing advancements in treatment options, such as antiparasitic drugs to improve efficacy and enhance patient accessibility, particularly in endemic regions. Antiparasitic drugs are medications used to treat infections caused by parasites, by targeting the parasite’s biological functions and disrupting its growth, reproduction, or survival within the host. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical company, received World Health Organization (WHO) prequalification approval for the active pharmaceutical ingredient (API) and formulation of miltefosine for the treatment of leishmaniasis or kala-azar. Miltefosine is an oral antiparasitic drug that works by disrupting the parasite's cell membrane and interfering with its metabolism, leading to cell death. It also inhibits parasite growth and survival, making it an effective oral treatment option for visceral leishmaniasis or kala azar.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Visceral Leishmaniasis Market? Gilead Sciences Inc. Partnered With World Health Organization To Boost Visceral Leishmaniasis Treatment Access

In January 2023, Gilead Sciences Inc., a US-based biopharmaceutical company that provides treatment for visceral leishmaniasis, extended its partnership with the World Health Organization (WHO) to facilitate better access to treatment options for visceral leishmaniasis. Through this partnership, Gilead Sciences is donating 304,700 vials of AmBisome (liposomal amphotericin B) to enhance the availability of essential medicines for the treatment of visceral leishmaniasis in high-burden countries, supporting global efforts to control and eliminate this life-threatening disease. The World Health Organization (WHO) is a Switzerland-based specialized agency that plays a key role in preventing, controlling, and eradicating visceral leishmaniasis through strategic initiatives and global health programs.

What Is The Regional Outlook For The Global Visceral Leishmaniasis Market?

North America was the largest region in the visceral leishmaniasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Visceral Leishmaniasis Market?

The visceral leishmaniasis market consists of revenues earned by entities by providing services such as drug development and distribution, vector control programs, and research and clinical trials. The market value includes the value of related goods sold by the service provider or included within the service offering. The visceral leishmaniasis market also includes sales of antileishmanial drugs, vaccines, vector control insecticides, recombinant antigen-based diagnostics, and polymerase chain reaction (PCR)-based detection kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Visceral Leishmaniasis Industry?

The visceral leishmaniasis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the visceral leishmaniasis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Visceral Leishmaniasis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.06 billion
Revenue Forecast In 2034	$1.32 billion
Growth Rate	CAGR of 5.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The visceral leishmaniasis market covered in this report is segmented – 1) By Treatment: Antiparasitic, Antifungal, Other Treatments 2) By Diagnosis Method: Serological Tests, Molecular Tests, Microscopy, Culture Methods 3) By Route Of Administration: Oral, Injectable, Other Routes Of Administration 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Antiparasitic: Pentavalent Antimonials, Miltefosine, Paromomycin, Sitamaquine, Combination Therapy 2) By Antifungal: Amphotericin B, Liposomal Amphotericin B (AmBisome), Azoles, Echinocandins, Polyenes 3) By Other Treatments: Immunotherapy, Monoclonal Antibodies, Vaccine-Based Approaches, Photodynamic Therapy, Gene Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Visceral Leishmaniasis Market Characteristics

3. Visceral Leishmaniasis Market Trends And Strategies

4. Visceral Leishmaniasis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Visceral Leishmaniasis Growth Analysis And Strategic Analysis Framework

5.1. Global Visceral Leishmaniasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Visceral Leishmaniasis Market Growth Rate Analysis

5.4. Global Visceral Leishmaniasis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Visceral Leishmaniasis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Visceral Leishmaniasis Total Addressable Market (TAM)

6. Visceral Leishmaniasis Market Segmentation

6.1. Global Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiparasitic

Antifungal

Other Treatments

6.2. Global Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Serological Tests

Molecular Tests

Microscopy

Culture Methods

6.3. Global Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

Other Routes Of Administration

6.4. Global Visceral Leishmaniasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

6.5. Global Visceral Leishmaniasis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

6.6. Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antiparasitic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pentavalent Antimonials

Miltefosine

Paromomycin

Sitamaquine

Combination Therapy

6.7. Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Amphotericin B

Liposomal Amphotericin B (AmBisome)

Azoles

Echinocandins

Polyenes

6.8. Global Visceral Leishmaniasis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunotherapy

Monoclonal Antibodies

Vaccine-Based Approaches

Photodynamic Therapy

Gene Therapy

7. Visceral Leishmaniasis Market Regional And Country Analysis

7.1. Global Visceral Leishmaniasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Visceral Leishmaniasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Visceral Leishmaniasis Market

8.1. Asia-Pacific Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Visceral Leishmaniasis Market

9.1. China Visceral Leishmaniasis Market Overview

9.2. China Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Visceral Leishmaniasis Market

10.1. India Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Visceral Leishmaniasis Market

11.1. Japan Visceral Leishmaniasis Market Overview

11.2. Japan Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Visceral Leishmaniasis Market

12.1. Australia Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Visceral Leishmaniasis Market

13.1. Indonesia Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Visceral Leishmaniasis Market

14.1. South Korea Visceral Leishmaniasis Market Overview

14.2. South Korea Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Visceral Leishmaniasis Market

15.1. Western Europe Visceral Leishmaniasis Market Overview

15.2. Western Europe Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Visceral Leishmaniasis Market

16.1. UK Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Visceral Leishmaniasis Market

17.1. Germany Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Visceral Leishmaniasis Market

18.1. France Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Visceral Leishmaniasis Market

19.1. Italy Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Visceral Leishmaniasis Market

20.1. Spain Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Visceral Leishmaniasis Market

21.1. Eastern Europe Visceral Leishmaniasis Market Overview

21.2. Eastern Europe Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Visceral Leishmaniasis Market

22.1. Russia Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Visceral Leishmaniasis Market

23.1. North America Visceral Leishmaniasis Market Overview

23.2. North America Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Visceral Leishmaniasis Market

24.1. USA Visceral Leishmaniasis Market Overview

24.2. USA Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Visceral Leishmaniasis Market

25.1. Canada Visceral Leishmaniasis Market Overview

25.2. Canada Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Visceral Leishmaniasis Market

26.1. South America Visceral Leishmaniasis Market Overview

26.2. South America Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Visceral Leishmaniasis Market

27.1. Brazil Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Visceral Leishmaniasis Market

28.1. Middle East Visceral Leishmaniasis Market Overview

28.2. Middle East Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Visceral Leishmaniasis Market

29.1. Africa Visceral Leishmaniasis Market Overview

29.2. Africa Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Visceral Leishmaniasis Market Competitive Landscape And Company Profiles

30.1. Visceral Leishmaniasis Market Competitive Landscape

30.2. Visceral Leishmaniasis Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Visceral Leishmaniasis Market Other Major And Innovative Companies

31.1. Takeda Pharmaceutical Company Limited

31.2. Gilead Sciences Inc.

31.3. Sun Pharmaceutical Industries Ltd.

31.4. Dr. Reddy's Laboratories

31.5. Aurobindo Pharma Limited

31.6. Cipla Limited

31.7. Zydus Lifesciences Limited

31.8. Glenmark Pharmaceuticals Limited

31.9. Alkem Laboratories Ltd

31.10. Xellia Pharmaceuticals

31.11. Knight Therapeutics Inc

31.12. Gufic Biosciences Ltd.

31.13. United Biotech Private Limited

31.14. DNDi

31.15. TLC

32. Global Visceral Leishmaniasis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Visceral Leishmaniasis Market

34. Recent Developments In The Visceral Leishmaniasis Market

35. Visceral Leishmaniasis Market High Potential Countries, Segments and Strategies

35.1 Visceral Leishmaniasis Market In 2029 - Countries Offering Most New Opportunities

35.2 Visceral Leishmaniasis Market In 2029 - Segments Offering Most New Opportunities

35.3 Visceral Leishmaniasis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Visceral Leishmaniasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Visceral Leishmaniasis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antiparasitic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Visceral Leishmaniasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Visceral Leishmaniasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Bristol-Myers Squibb Company Financial Performance

Table 81: Abbott Laboratories Financial Performance

Table 82: Novartis AG Financial Performance

Table 83: GSK plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Visceral Leishmaniasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Visceral Leishmaniasis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antiparasitic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Visceral Leishmaniasis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Visceral Leishmaniasis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Bristol-Myers Squibb Company Financial Performance

Figure 81: Abbott Laboratories Financial Performance

Figure 82: Novartis AG Financial Performance

Figure 83: GSK plc Financial Performance

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Anticoagulants Global Market Report 2025 – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Di...

Psoriasis Global Market Report 2025 – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor ), By Drug Types (Small molecules, Biologics ), By Disease Indication (Pla...

Veterinary Parasiticides Global Market Report 2025 – By Type (Endoparasiticides, Ectoparasiticides, Endectocides), By Product (Oral Liquids, Tablets, Injectables, Sprays, Other Products), By Application (Farm Animals, Co...

Bioceramics Global Market Report 2025 – By Type (Bioinert, Bioactive, Bioresorbable), By Material (Aluminum Oxide, Zirconia, Calcium Phosphate, Other Materials), By Application (Orthopedic, Dental Implants, Biomedical, O...

Exosome Diagnostic And Therapeutic Global Market Report 2025 – By Product (Instruments, Software, Reagents And Kits), By Application (Diagnostics, Therapeutic), By End User (Academic And Research Institutes, Pharmaceutic...

Mucolipidosis II Global Market Report 2025 – By Treatment (Antibiotics, Physical Therapy, Hip Replacement, Experimental Therapies, Other Treatments), By Mode Of Administration (Injectable, Oral, Other Modes Of Administra...

Systemic Aspergillosis And Systemic Candidiasis Global Market Report 2025 – By Type (Systemic Oral Azoles, Voriconazole, Liposomal Amphotericin B, Topical Antifungal Agents, Other Types), By Application (Allergic Broncho...

Frequently Asked Questions

What is the definition of the Visceral Leishmaniasis market?

How will the Visceral Leishmaniasis market drivers and restraints affect the market dynamics? What forces will shape the Visceral Leishmaniasis industry going forward?

The market major growth driver - Rise In Malnutrition Fueling The Growth Of The Market Due To Weakened Immunity And Increasing Susceptibility. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Visceral Leishmaniasis market?

The visceral leishmaniasis market size has grown strongly in recent years. It will grow from $1 billion in 2024 to $1.06 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing disease burden, rising government funding, the introduction of amphotericin B, development of miltefosine, growing awareness campaigns, improved healthcare access in endemic regions, and establishment of public-private partnerships. The visceral leishmaniasis market size is expected to see strong growth in the next few years. It will grow to " $1.32 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing investment in vaccine development, enhanced global disease surveillance programs, increasing public-private collaborations, improved funding for neglected tropical diseases and development of gene-based therapies. Major trends in the forecast period include clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing, artificial intelligence (AI)-driven drug discovery, nanotechnology-enhanced drug delivery, next-generation sequencing for parasite analysis, wearable biosensors for early detection, blockchain for medical supply chain management, smartphone-based diagnostic tools and three-dimensional (3D) bioprinting for personalized treatment research. For further insights on this market, request a sample here

How is the Visceral Leishmaniasis market segmented?

The visceral leishmaniasismarket covered in this report is segmented –
1) By Treatment: Antiparasitic; Antifungal; Other Treatments
2) By Diagnosis Method: Serological Tests; Molecular Tests; Microscopy; Culture Methods
3) By Route Of Administration: Oral; Injectable; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users Subsegments:
1) By Antiparasitic: Pentavalent Antimonials; Miltefosine; Paromomycin; Sitamaquine; Combination Therapy
2) By Antifungal: Amphotericin B; Liposomal Amphotericin B (AmBisome); Azoles; Echinocandins; Polyenes
3) By Other Treatments: Immunotherapy; Monoclonal Antibodies; Vaccine-Based Approaches; Photodynamic Therapy; Gene Therapy For further insights on this market, request a sample here

Which region has the largest share of the Visceral Leishmaniasis market? What are the other regions covered in the report?

North America was the largest region in the visceral leishmaniasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the visceral leishmaniasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Visceral Leishmaniasis market?

What are the key trends in the Visceral Leishmaniasis market?

Major trends in this market include Advancements In Oral Antiparasitic Therapies For Visceral Leishmaniasis. For further insights on this market, request a sample here.